Portrait
John Timberlake , President & Chief Executive Officer

John Timberlake has served as our chief executive officer, president and chief commercial officer and a member of our board of directors since February 2016, prior to which he served as president and chief commercial officer since August 2008. Before becoming chief executive officer, president and chief commercial officer, Mr. Timberlake was a general manager with our company from September 2006 to August 2008. Prior to joining Valeritas, Mr. Timberlake held positions of increasing responsibility from 1991 to 2006 at Sanofi-Aventis (now Sanofi), with his last role as vice president of diabetes marketing, where he was responsible for the diabetes franchise, including the brands Lantus, Apidra and Amaryl. While at Sanofi, Mr. Timberlake had extensive experience and commercial responsibilities for new products in development across multiple therapeutic areas, including inhaled insulin and other metabolic products. Prior to working in the healthcare industry, Mr. Timberlake was a manager with Deloitte & Touche LLP from 1986 to 1991 and was both a certified management accountant and a certified public accountant. He earned a B.S. in Accounting at Northwest Missouri State University, an M.S. in management from Purdue University and an MBA from ESC Rouen in France (now NEOMA Business School).

John Timberlake , President & Chief Executive Officer

John Timberlake has served as our chief executive officer, president and chief commercial officer and a member of our board of directors since February 2016, prior to which he served as president and chief commercial officer since August 2008. Before becoming chief executive officer, president and chief commercial officer, Mr. Timberlake was a general manager with our company from September 2006 to August 2008. Prior to joining Valeritas, Mr. Timberlake held positions of increasing responsibility from 1991 to 2006 at Sanofi-Aventis (now Sanofi), with his last role as vice president of diabetes marketing, where he was responsible for the diabetes franchise, including the brands Lantus, Apidra and Amaryl. While at Sanofi, Mr. Timberlake had extensive experience and commercial responsibilities for new products in development across multiple therapeutic areas, including inhaled insulin and other metabolic products. Prior to working in the healthcare industry, Mr. Timberlake was a manager with Deloitte & Touche LLP from 1986 to 1991 and was both a certified management accountant and a certified public accountant. He earned a B.S. in Accounting at Northwest Missouri State University, an M.S. in management from Purdue University and an MBA from ESC Rouen in France (now NEOMA Business School).

Geoffrey Jenkins , Executive Vice President, Manufacturing, Operations, and R&D

Geoffrey Jenkins has served as our executive vice president, manufacturing, operations and research & development since he joined Valeritas in April 2009. Prior to joining Valeritas, Mr. Jenkins was vice president of worldwide operations for Inverness Medical Innovations, a healthcare technology company, from 2005 to 2009. From 2000 to 2005, he was president and founding partner of UV-Solutions, LLC, a healthcare technology company, and from 1997 to 1999, he was chief operating officer of MDI Instruments, Inc., a healthcare technology company. Mr. Jenkins was also corporate vice president of operations of MediSense, Inc. from 1991 to 1997. Prior to becoming corporate vice president of operations, he held various other positions in operations and engineering management with MediSense from 1984 to 1991. Mr. Jenkins earned a Bachelor of Arts and a Bachelor of Science from Clarkson University.

Erick Lucera , Executive Vice President & Chief Financial Officer

Erick Lucera joined the company as Chief Financial Officer in August 2016. Prior to joining Valeritas, Mr. Lucera served as Chief Financial Officer, Treasurer and Secretary of Viventia Bio. From 2012 to 2015, he was Vice President, Corporate Development at Aratana Therapeutics, a veterinary biopharmaceutical company. While at Aratana, he helped grow the company’s product pipeline through a series of acquisitions and in licensing transactions financed through 5 public and private offerings of nearly $250 million. In 2012, he served as Vice President, Corporate Development at Sunshine Heart, a medical device manufacturer. Before his career as a healthcare company executive, Mr. Lucera spent over 15 years in investment management as a healthcare analyst at Eaton Vance, the portfolio manager of the Triathlon Life Sciences Fund at Intrepid Capital and as head of the healthcare research team at Independence Investments. He holds a CPH from Harvard University, and MS in quantitative finance from Boston College, an MBA from Indiana University Bloomington, and a BS in accounting from the University of Delaware. Mr. Lucera has obtained CFA, CMA, and CPA designations.

Matthew Nguyen , PharmD , Chief Commercial Officer

Matthew Nguyen has served as senior vice president, commercial since February 2016, prior to which he served as vice president for integrated healthcare management since joining Valeritas in September 2006. Prior to joining Valeritas, Mr. Nguyen was a new business development director for Janssen, LP, a division of Johnson & Johnson, from 2005 to 2006. Prior to joining Janssen, LP, he served as head of health economics research for metabolism, new product marketing and head of analytics and commercial effectiveness for the CNS business unit at Sanofi from 2000 to 2005. Mr. Nguyen earned a Bachelor of Science in pharmacy and a Doctor of Pharmacy from the Philadelphia College of Pharmacy and Science. He also completed a fellowship in health economics and outcomes research in conjunction with Thomas Jefferson University Hospital and Janssen Pharmaceuticals, Inc. and earned an MBA from Rutgers University.

Joseph Saldanha , Chief Business Officer

Joseph Saldanha joined Valeritas in January 2018. He has over 15 years of diabetes experience and over 25 years in the industry. In roles prior to joining Valeritas, Mr. Saldanha spent several years at Sanofi and its predecessors, launching Actonel for osteoporosis in the US, and for Lantus in international markets from Paris. He worked in Business Development at Johnson and Johnson Diabetes (LifeScan for self-monitoring blood glucose and Animas for insulin pumps). Mr. Saldanha has also worked in the United Arab Emirates in a General Management role with responsibility for inulin API, diabetes orals and injectables, and distribution of Dexcom CGM for the Middle-Eastern markets. He has worked on the Aventis-Pfizer partnership for Exubera and in commercial and Business Development roles for MannKind. Mr. Saldanha earned a Bachelor of Science degree from Drexel University and a Master of Science degree from the University of Pennsylvania, both in Philadelphia.

Cathy DeRose , Senior Director for Human Resources

Cathy DeRose joined Valeritas in 2018 to lead the human resource function for the company. Cathy is responsible for leading, designing and deploying innovative and impactful human resources services, policies and programs that are aligned with Valeritas’ short and long term strategic objectives. She is a trusted advisor and partner with the Executive and Operating Leadership teams. Cathy oversees our talent acquisition and retention plans, employee relations, performance management, organizational development, employment practices and policies, compensation and benefit administration.

Cathy has extensive experience in leading the Human Resource function at several different organizations including several multi-site U.S. and Global Manufacturers, as well as with pharmaceutical service providers. Cathy earned her M.S. Administration from Central Michigan University, a B.A. in Political Science from Arcadia University and is a member of the Society for Human Resources Management (SHRM).